BTSG · BrightSpring Health Services, Inc.
$61.71
+1.48 (+2.46%)
At close · Aug 14
Market Cap
$12.21B
Shares
197.86M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$61.71
Open$59.65
Day$59.12–61.88
52W close$22.44–72.91
Avg vol 30d4.1M
Short int8.4M · 4.2% float · 1.5d
Short vol47%
Last earningsJul 31, 2026
DataJan 2024–Aug 2026
Filing10-Q · Jul 31
Up next
Next earnings call
Oct 29, 2026
Est · unconfirmed
· in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 31, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Sell
Momentum
Strong
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+28%
above
Price vs 50-day avg
−7%
below
RSI (14)
44
neutral
MACD trend
Negative
52-week position
78%
mid-range
Momentum
relative strength
1-month return
−13%
trailing
6-month return
+54%
trailing
YTD return
+65%
this year
Relative strength
+41%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $66 › 200d $48 — 50d above 200d
Institutional flow
Accumulating
+22% holders QoQ · +125 funds added
Insider flow
Distributing
Net -$1.7B over 90 days · 100% sells
Short interest
Falling
4.25% of float · ▼ -15.7% MoM · 1.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
429 holders — near 2-yr high, broad support
Squeeze score
43
elevated · 0–100
Fundamentals
Revenue growth
+28%
Y/Y
Gross margin
12%
contracting
EPS growth
+1067%
Y/Y
Free cash flow
$394.7M
Valuation
P/E 37.4
below peers
Balance sheet
$2.4B
net debt
Quant / Vol
risk profile
Volatility
44%
annualized · 1-yr
Max drawdown
−21%
past year
ATR
5.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 31, 2026
Revenues
· full year 2026
$15.1B – $15.43B
Pharmacy Segment Revenue
· full year 2026
$13.2B – $13.5B
Provider Segment Revenue
· full year 2026
$1.9B – $1.93B
Total Adjusted EBITDA
· full year 2026
Non-GAAP
$820M – $845M
Prior guidance
period ended
· from the Earnings Call filed Sep 30, 2025
Adjusted EBITDA
· 2025
$605M – $615M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+28%
Bullish
Price vs 50-day avg
−7%
Bearish
RSI (14)
44
Neutral
MACD trend
Negative
Bearish
52-week position
78%
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $66 › 200d $48 — 50d above 200d
Institutional flow
Accumulating
+22% holders QoQ · +125 funds added
Insider flow
Distributing
Net -$1.7B over 90 days · 100% sells
Short interest
Falling
4.25% of float · ▼ -15.7% MoM · 1.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
429 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $22
Now $62 · 78%
Range high $73
vs 200-day avg +28%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $206M | Q2 2026 | — |
|
|
|||
| Home Health Care average daily census | 46,448 | Three Months Ended June 30, 2026 | — |
|
|
|||
| Leverage | 2.15 | As of June 30, 2026 | — |
| Personal Care persons served | 16,357 | Three Months Ended June 30, 2026 | — |
|
|
|||
| Pharmacy Solutions segment EBITDA non-GAAP | $180M | Three Months Ended June 30, 2026 | — |
|
|
|||
| Prescriptions dispensed | 10,844,038 | Three Months Ended June 30, 2026 | — |
|
|
|||
| Provider Services segment EBITDA non-GAAP | $75M | Three Months Ended June 30, 2026 | — |
|
|
|||
| Rehab Care persons served | 7,755 | Three Months Ended June 30, 2026 | — |
|
|
|||
| Total Company Adjusted EBITDA non-GAAP | $206M | Three Months Ended June 30, 2026 | — |
|
|
|||
| Total Segment Adjusted EBITDA non-GAAP | $255M | Three Months Ended June 30, 2026 | — |
|
|
|||
| Gross Profit per script | $21.64 | full year 2025 | — |
| Revenue per script | $263.93 | full year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BTSG
this stock
BrightSpring Health Services, Inc.
|
$12.21B | +64.8% | +28.2% | 37.4 | 4.2% |
|
VEEV
Veeva Systems Inc
|
$39.23B | +9.2% | +28.1% | 42.8 | 4.5% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$15.41B | -18.8% | — | — | 0.0% |
|
TEM
Tempus AI, Inc.
|
$9.85B | -11.8% | +83.4% | — | 18.4% |
|
HQY
Healthequity, Inc.
|
$8.76B | +14.3% | +28.7% | 39.2 | 5.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BTSG | -1.2% | -12.7% | +54.3% | +3.4% | +64.8% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -1.6% | -17.2% | +40.5% | -0.6% | +50.9% |
Key facts
CIK
1865782
CUSIP
10950A106
13F (30d)
414 filings
409 filers
Visit website
Investor relations